Shuttle Pharmaceuticals Advances Glioblastoma Clinical Trials
PremiumCompany AnnouncementsShuttle Pharmaceuticals Advances Glioblastoma Clinical Trials
15d ago
Shuttle’s clinical trial site enrollments complete for Phase 2 of IPdR for GBM
Premium
The Fly
Shuttle’s clinical trial site enrollments complete for Phase 2 of IPdR for GBM
15d ago
Shuttle Pharmaceuticals to Present at ThinkEquity Conference
Premium
Company Announcements
Shuttle Pharmaceuticals to Present at ThinkEquity Conference
15d ago
Shuttle Pharmaceuticals regains compliance with Nasdaq requirement
PremiumThe FlyShuttle Pharmaceuticals regains compliance with Nasdaq requirement
3M ago
Shuttle Pharmaceuticals receives noncompliance notification from Nasdaq
Premium
The Fly
Shuttle Pharmaceuticals receives noncompliance notification from Nasdaq
3M ago
Shuttle Pharmaceuticals opens enrollment in Ropidoxuridine trial
Premium
The Fly
Shuttle Pharmaceuticals opens enrollment in Ropidoxuridine trial
3M ago
Shuttle Pharmaceuticals provides Q1 update
PremiumThe FlyShuttle Pharmaceuticals provides Q1 update
6M ago
Shuttle Pharmaceuticals files to sell subscription rights to buy $4.5M in units
Premium
The Fly
Shuttle Pharmaceuticals files to sell subscription rights to buy $4.5M in units
7M ago
Shuttle Pharmaceuticals Advances Prostate Cancer Diagnostics Funding
Premium
Company Announcements
Shuttle Pharmaceuticals Advances Prostate Cancer Diagnostics Funding
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100